 We don't just provide a simple binary result back to the provider, meaning yes, no, there is a signal for cancer. We do provide that information and that's super valuable. That's the first layer of information. But that coin we try and identify, is that a euro? Is that a pound? Why is that coin different? Where is that coming from? We call it the CSO or the Cancer Signal of Origin. We think that is absolutely a fundamental component of this platform and this really new field that we're developing because there's a lot of other test developers that are trying to crack this nut as well and trying to really bring new innovations into this really exciting multi-cancer early detection field. We really think that that component of identifying where this potential signal is coming from, whether or not it's the long gut or the head and neck for instance, is super valuable as that second layer of information to the provider so that they don't have to do pan scans and they don't have to go on a broad diagnostic odyssey to try and find where that signal is coming from and then lump it out, do surgery irradiation or try and actually remove the tumor. We actually give that CSO, that Cancer Signal of Origin information back is the second layer of information so that the next diagnostic stage is more targeted and we think that's really a fundamental piece of this field.